1Dermirci H,Mccarmich SA,Finger PT.Topical mitomycin chemotherapyfor conjunctival malignant melanoma and primary acquired melanosis withatypia:clinical experience with histopathologic observations[J].ArchOphthalmol,2000;118(7):885-91. 被引量：1
2Tuomaala S,Eskelin S,Tarkkann A,et al.Population-based assessment ofclinical characteristics predicting outcome of conjunctival melanoma inwhites[J].Invest ophthalmol Vis Sic,2002;43(11):3399-408. 被引量：1
3Vaughan D,Asbury T,Riordan-Eva P.General Ophthalmology[M].15thed.Prentice Hall Ineenationnal,Inc,1999:116-7. 被引量：1
4Shields CL,Shields JA,Gunduz K,et al.Conjunctival melanoma:risk fac-tors for recurrence,exenteration,metastasis,and death in 150 consecutivepatients[J]Arch Ophthalmol,2000;118(11):1497-507. 被引量：1
5Rodriguez-Ares T,Tourino R,De Rojas V,et al.Topical mitomycin C inthe treatment of pigmented conjunctival lesions[J].Cornea,2003;22(2):114-7. 被引量：1
6Stannard CE,Sealy GH,Hering ER,et al.Malignant Melanoma of theeyelid and Palpebral Conjunctiva.Treated with iodine-125 brachy therapy[J].Ophthalmology,2000;107(5):951-8. 被引量：1
